The global GLP-1 analogues market size is expected to grow at a CAGR of 14% during the forecast period. The rising prevalence of type 2 diabetes and obesity, increasing adoption for chronic weight management among non-diabetic populations, expansion of pharmaceutical R&D pipelines, and growing demand in emerging markets with high metabolic disease burden are key … Continue reading Global GLP-1 Analogues Market Size & Trends Report Segmented by Product (Ozempic, Mounjaro, Wegovy, Rybelsus, Saxenda), Route of Administration (Subcutaneous, Oral), Application (Diabetes, Obesity), End-user Analysis & Regional Forecast to 2031